Consulting services for improving contraception methods
Official title: PHARMACOLOGY CONSULTING SERVICES for Contraception Research
Funded at Gardner Pharmacology LLC · NIH-11180598 · Data updated 2026-11-12
This study is all about improving birth control methods by working with experts to make sure new contraceptive drugs are safe and effective, helping to prevent unplanned pregnancies for everyone who needs reliable options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gardner Pharmacology LLC NIH-funded |
| Lab location | 1 site (Vienna, United States) |
| Project start | September 14, 2024 |
| Project end | September 13, 2025 |
| Funding year | 2024 |
| Award (this year) | $50,000 |
| NIH project number | 75N94024P00469-0-0-1 |
| Project ID | NIH-11180598 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals seeking reliable contraceptive options or those interested in participating in contraceptive clinical trials.
✕Less likely to help
Patients who are not interested in contraception or those who have already found effective contraceptive methods may not benefit from this research.
What this research studies
This research focuses on enhancing contraceptive methods by providing expert pharmacology consulting services. The Contraception Research Branch of NICHD aims to prevent unintended pregnancies through better drug development and evaluation. The project involves liaising with various research facilities to ensure that studies meet pharmacokinetic requirements, analyzing existing data, and advising on optimal sampling strategies. Additionally, it includes reviewing bioanalytical methodologies and generating pharmacokinetic reports to support ongoing studies.
Why it matters
Potential benefit: If successful, this research could lead to more effective contraceptive methods, reducing the rate of unintended pregnancies.
How similar studies have gone: Previous research in pharmacology consulting for contraceptive development has shown promise, indicating that this approach could yield beneficial results.
Where this research is happening
-
Gardner Pharmacology LLC
Vienna, United States Active
Researchers
- Principal investigator: Gardner, Erin — Gardner Pharmacology LLC
- Study coordinator: Gardner, Erin
Related research
Other NIH-funded projects on the same topics.
-
Mobile health support to boost PrEP and contraception use among young women in Zambia
A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.
-
Blocking CFTR in the cervix to prevent conception without hormones
A non-hormonal approach aims to stop sperm from entering the uterus by making cervical mucus too thick for sperm, potentially offering a new contraception option.
-
Long‑lasting antibody vaginal ring for non‑hormonal birth control
Testing a vaginal ring that slowly releases an antibody to trap sperm and prevent pregnancy for people seeking non‑hormonal contraception.
-
A woman-controlled, nonhormonal on-demand contraceptive device
This project is creating a woman-controlled vaginal device that releases a fabric-like polymer which thickens on contact with semen to help prevent pregnancy.
-
Vaginal ring releasing non-hormonal antibody contraception for month-long use
A monthly vaginal ring delivers a non-hormonal antibody-based contraceptive, offering a convenient, user-controlled option for women who want to avoid daily dosing or invasive procedures.
-
On-demand non-hormonal vaginal contraception with a fast-dissolving antibody tablet
A new on-demand vaginal tablet dissolves quickly to release a monoclonal antibody for non-hormonal contraception.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.